SCHEMBL913155

SCHEMBL913155

CC1(O)CCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24269952 1.00
SCHEMBL20052992 1.00
SCHEMBL11180440 0.83
SCHEMBL23514935 0.83
SCHEMBL22926524 0.83
SCHEMBL562149 0.81
Hydrochloric Acid SCHEMBL29161648 0.79 ALDH1A1 (0.32)
SCHEMBL9352724 0.79 TTR (0.38)
Isobutane SCHEMBL586014 0.74 LMNA (0.38)
SCHEMBL24477670 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1057823-B1 Process for producing 3-methyltetrahydrofuran KURARAY CO (JP) 2005-09-21 EP claimed
US-6239295-B1 Process for producing 3-methyltetrahydrofuran, and process for producing an intermediate thereof KURARAY CO., LTD (JP) 2001-05-29 US claimed
EP-1057823-A2 Process for producing 3-methyltetrahydrofuran, and process for producing an intermediate thereof KURARAY CO., LTD. (JP) 2000-12-06 EP claimed
US-20250092042-A1 HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. 2025-03-20 US disclosed
US-12157737-B2 Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof NOVARTIS AG (CH) 2024-12-03 US disclosed
US-20240383901-A1 SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2024-11-21 US disclosed
US-20240208923-A1 SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION JNANA THERAPEUTICS INC. 2024-06-27 US disclosed
EP-3722287-B1 METHOD FOR PRODUCING CYCLIC ETHER KURARAY CO (JP) 2024-02-21 EP disclosed
US-20240043425-A1 HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF NOVARTIS AG (CH) 2024-02-08 US disclosed
CN-117447520-A Benzo ring substituted pyrimidine compound and application thereof 广州利弗克医药科技有限公司 2024-01-26 CN disclosed
EP-4269403-A1 AROMATIC HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF GT Apeiron Therapeutics Limited (HK) 2023-11-01 EP disclosed
US-5990155-A VIRICIDES AGAINST THE HIV-1 AND HIV-2 VIRUSES; REVERSE TRANSCRIPTASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 1999-11-23 US disclosed
CN-1184474-A Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease VERTEX PHARMA (US) 1998-06-10 CN disclosed
EP-0833826-A1 OXYGENATED-HETEROCYCLE CONTAINING SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE Vertex Pharmaceuticals Incorporated (US) 1998-04-08 EP disclosed
US-5691372-A Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease VERTEX PHARMACEUTICALS INCORPORATED (US) 1997-11-25 US disclosed
US-5597400-A PLANT GROWTH REGULATORS NONOMURA ARTHUR M (US) 1997-01-28 US disclosed
WO-1996033187-A1 OXYGENATED-HETEROCYCLE CONTAINING SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE VERTEX PHARMACEUTICALS INCORPORATED (US) 1996-10-24 WO disclosed
EP-0645962-A4 METHODS AND COMPOSITIONS FOR ENHANCING CARBON FIXATION IN PLANTS. NONOMURA ARTHUR M (US) 1995-07-05 EP disclosed
EP-0645962-A1 METHODS AND COMPOSITIONS FOR ENHANCING CARBON FIXATION IN PLANTS NONOMURA, Arthur M. (US) 1995-04-05 EP disclosed
WO-1994000009-A1 METHODS AND COMPOSITIONS FOR ENHANCING CARBON FIXATION IN PLANTS NONOMURA ARTHUR M (US) 1994-01-06 WO disclosed